There has been some recent discussion about how to talk about male breast cancer, specifically whether to use the word breast or instead euphemize it with ‘chest’. I wanted to share my opinion, which is […]
Nearly 7 years ago I did an analysis of clinical trials and found that 32% of trials allowed both male and female patients to enroll, as I wrote on this site and in a publication, […]
I was asked recently why male mice are not used for breast cancer work – here is my long answer.
Cancer clinical trials are research studies that involve people, including new interventions like medicines and surgeries. There are thousands of trials available in the US and across the globe. Finding one that might be a […]
A study by Dr. Henneghan is looking for participants! Please share this with as many people as possible – particularly men who are breast cancer survivors, as Dr. Henneghan has adjusted to the study to […]
A study on improving brain function in breast cancer survivors who have had chemotherapy is now accepting men! This study is evaluating how a meditation intervention improves cognitive functioning after breast cancer treatment. If you […]
First – apologies to readers – I have not posted in a good while, for life reasons. I am doing very well and had the chance of a lifetime earlier this year to join the […]
Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Doebar SC, Slaets L, Cardoso F, Giordano SH, Bartlett JM, Tryfonidis K, Dijkstra NH, Schröder CP, van Asperen CJ, Linderholm […]
Retesting BRCA1/BRCA2 mutation negative male breast cancer patients using next generation sequencing technologies Piera Rizzolo Valentina Silvestri and Laura Ottini Breast Cancer Res Treat DOI 10.1007/s10549-017-4108-9 Background BRCA1 and BRCA2 are well known, high penetrance […]
Welcome to October – the month we think more about breast cancer than usual. This is a quick post and appeal to my regular readers and a welcome to first time visitors. I have written […]
